APRE
Aprea Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.79
−1.49%Aug 12, 2026, 12:30 UTC
Aprea Therapeutics announced its financial results for the second quarter of 2026.
Source:
NASDAQ · Healthcare · Biotechnology · US
Aug 12, 2026, 12:30 UTC